These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17541020)
1. In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Wang MD; Franklin V; Marcel YL Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1837-42. PubMed ID: 17541020 [TBL] [Abstract][Full Text] [Related]
2. Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice. Calpe-Berdiel L; Rotllan N; Palomer X; Ribas V; Blanco-Vaca F; EscolĂ -Gil JC Biochim Biophys Acta; 2005 Dec; 1738(1-3):6-9. PubMed ID: 16413225 [TBL] [Abstract][Full Text] [Related]
3. Effect of sulfonylurea agents on reverse cholesterol transport in vitro and vivo. Terao Y; Ayaori M; Ogura M; Yakushiji E; Uto-Kondo H; Hisada T; Ozasa H; Takiguchi S; Nakaya K; Sasaki M; Komatsu T; Iizuka M; Horii S; Mochizuki S; Yoshimura M; Ikewaki K J Atheroscler Thromb; 2011; 18(6):513-30. PubMed ID: 21636950 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969 [TBL] [Abstract][Full Text] [Related]
5. Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways. Wang MD; Kiss RS; Franklin V; McBride HM; Whitman SC; Marcel YL J Lipid Res; 2007 Mar; 48(3):633-45. PubMed ID: 17148552 [TBL] [Abstract][Full Text] [Related]
6. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. Ogura M; Ayaori M; Terao Y; Hisada T; Iizuka M; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Sasaki M; Komatsu T; Ozasa H; Ohsuzu F; Ikewaki K Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1980-7. PubMed ID: 21817095 [TBL] [Abstract][Full Text] [Related]
7. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556 [TBL] [Abstract][Full Text] [Related]
8. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Wang X; Collins HL; Ranalletta M; Fuki IV; Billheimer JT; Rothblat GH; Tall AR; Rader DJ J Clin Invest; 2007 Aug; 117(8):2216-24. PubMed ID: 17657311 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Rosenblat M; Vaya J; Shih D; Aviram M Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011 [TBL] [Abstract][Full Text] [Related]